Epigallocatechin-3-gallate (EGCG) up-regulates miR-15b expression thus attenuating store operated calcium entry (SOCE) into murine CD4+ T cells and human leukaemic T cell lymphoblasts

CD4+ T cells are key elements in immune responses and inflammation. Activation of T cell receptors in CD4+ T cells triggers cytosolic Ca2+ release with subsequent store operated Ca2+ entry (SOCE), which is accomplished by the pore forming Ca2+ release activated Ca2+ (CRAC) channel Orai1 and its regulator stromal cell-interaction molecule 2 (STIM2). Green tea polyphenol epigallocatechin-3-gallate (EGCG) acts as a potent anti-inflammatory and anti-oxidant agent for various types of cells including immune cells. However, how post-transcriptional gene regulators such as miRNAs are involved in the regulation of Ca2+ influx into murine CD4+ T cells and human Jurkat T cells through EGCG is not defined. EGCG treatment of murine CD4+ T cells significantly down-regulated the expression of STIM2 and Orai1 both at mRNA and protein levels. Furthermore, EGCG significantly decreased SOCE in both murine and human T cells. EGCG treatment increased miRNA-15b (miR-15b) abundance in both murine and human T cells. Bioinformatics analysis reveals that miR-15b, which has a STIM2 binding site, is involved in the down-regulation of SOCE. Overexpression of miR-15b significantly decreased the mRNA and protein expression of STIM2 and Orai1 in murine T cells. Treatment of Jurkat T cells with 10 μM EGCG further decreased mTOR and PTEN protein levels. EGCG decreased mitochondrial membrane potential (MMP) in both human and murine T cells. In conclusion, the observations suggest that EGCG inhibits the Ca2+ entry into murine and human T cells, an effect accomplished at least in part by up-regulation of miR-15b.

[1]  F. Lang,et al.  MicroRNAs regulate T‐cell production of interleukin‐9 and identify hypoxia‐inducible factor‐2α as an important regulator of T helper 9 and regulatory T‐cell differentiation , 2016, Immunology.

[2]  F. Lang,et al.  Role of Dicer Enzyme in the Regulation of Store Operated Calcium Entry (SOCE) in CD4+ T Cells , 2016, Cellular Physiology and Biochemistry.

[3]  Y. Liu,et al.  (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN. , 2016, Molecular medicine reports.

[4]  P. Pinton,et al.  ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca(2+) signaling. , 2016, Biochimica et biophysica acta.

[5]  B. Niemeyer.  Changing calcium: CRAC channel (STIM and Orai) expression, splicing, and posttranslational modifiers. , 2016, American journal of physiology. Cell physiology.

[6]  M. Găman,et al.  Cellular determinants involving mitochondrial dysfunction, oxidative stress and apoptosis correlate with the synergic cytotoxicity of epigallocatechin-3-gallate and menadione in human leukemia Jurkat T cells. , 2016, Pharmacological research.

[7]  F. Lang,et al.  MicroRNA-15b/16 Enhances the Induction of Regulatory T Cells by Regulating the Expression of Rictor and mTOR , 2015, The Journal of Immunology.

[8]  Neha Singh,et al.  Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG) , 2015, Nutrition Journal.

[9]  G. Bultynck,et al.  p53 and Ca2+ signaling from the endoplasmic reticulum: partners in anti-cancer therapies , 2015, Oncoscience.

[10]  Hong Wang,et al.  Gene regulation mediated by microRNAs in response to green tea polyphenol EGCG in mouse lung cancer , 2014, BMC Genomics.

[11]  T. Snutch,et al.  Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels. , 2014, Cell calcium.

[12]  L. Zeng,et al.  Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells , 2014, Front. Endocrinol..

[13]  Sung-Hwan Park,et al.  EGCG Attenuates Autoimmune Arthritis by Inhibition of STAT3 and HIF-1α with Th17/Treg Control , 2014, PloS one.

[14]  M. Cho,et al.  Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets. , 2014, Immunology letters.

[15]  Michael Loran Dustin,et al.  Interference with Ca2+ release activated Ca2+ (CRAC) channel function delays T‐cell arrest in vivo , 2013, European journal of immunology.

[16]  F. Lang,et al.  AMPKα1-Sensitivity of Orai1 and Ca2+ Entry in T - Lymphocytes , 2013, Cellular Physiology and Biochemistry.

[17]  Jingting Jiang,et al.  Mechanism of T cell regulation by microRNAs , 2013, Cancer biology & medicine.

[18]  P. Pandolfi,et al.  Identification of PTEN at the ER and MAMs and its regulation of Ca2+ signaling and apoptosis in a protein phosphatase-dependent manner , 2013, Cell Death and Differentiation.

[19]  H. Takayanagi,et al.  Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. , 2013, Immunity.

[20]  S. Koyasu,et al.  Role of PI3K/Akt and mTOR complexes in Th17 cell differentiation , 2013, Annals of the New York Academy of Sciences.

[21]  Mrutyunjay Suar,et al.  Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity* , 2012, The Journal of Biological Chemistry.

[22]  S. Feske,et al.  Regulation of lymphocyte function by ORAI and STIM proteins in infection and autoimmunity , 2012, The Journal of physiology.

[23]  J. Powell,et al.  All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells , 2012, Front. Immun..

[24]  F. Soler,et al.  Inhibition of the intracellular Ca2+ transporter SERCA (Sarco-Endoplasmic Reticulum Ca2+-ATPase) by the natural polyphenol epigallocatechin-3-gallate , 2012, Journal of Bioenergetics and Biomembranes.

[25]  S. Feske,et al.  Ion channels , 2013, Thorax.

[26]  Dalya R. Soond,et al.  Does the PI3K pathway promote or antagonize regulatory T cell development and function? , 2012, Front. Immun..

[27]  Markus Waldeck-Weiermair,et al.  Studying mitochondrial Ca2+ uptake – A revisit , 2012, Molecular and Cellular Endocrinology.

[28]  S. Shankar,et al.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. , 2011, Biochemical pharmacology.

[29]  R. Bruno,et al.  Induction of regulatory T cells by green tea polyphenol EGCG. , 2011, Immunology letters.

[30]  R. Shytle,et al.  Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction. , 2011, Journal of Alzheimer's disease : JAD.

[31]  S. Feske,et al.  T‐cell‐specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells , 2010, European journal of immunology.

[32]  C. Ra,et al.  Epigallocatechin-3-gallate inhibits mast cell degranulation, leukotriene C4 secretion, and calcium influx via mitochondrial calcium dysfunction. , 2010, Free radical biology & medicine.

[33]  Dayong Wu,et al.  Epigallocatechin-3-gallate directly suppresses T cell proliferation through impaired IL-2 utilization and cell cycle progression. , 2010, The Journal of nutrition.

[34]  Samuel K. Shimp,et al.  Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells , 2010, Cellular and Molecular Immunology.

[35]  Dayong Wu,et al.  Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling. , 2009, Free radical biology & medicine.

[36]  V. Barr,et al.  Dynamic movement of the calcium sensor STIM1 and the calcium channel Orai1 in activated T-cells: puncta and distal caps. , 2008, Molecular biology of the cell.

[37]  A. Rao,et al.  Calcium signaling in lymphocytes. , 2008, Current opinion in immunology.

[38]  E. Lamperti,et al.  Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance , 2008, Nature Immunology.

[39]  C. Benoist,et al.  The AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells , 2008, The Journal of experimental medicine.

[40]  T. Franke.  Akt-interacting proteins: attractive opposites. focus on "Carboxy-terminal modulator protein induces Akt phosphorylation and activation, thereby enhancing antiapoptotic, glycogen synthetic, and glucose uptake pathways". , 2007, American journal of physiology. Cell physiology.

[41]  B. E. Foreman,et al.  Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals , 2007, Acta Pharmacologica Sinica.

[42]  C. Elger,et al.  Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias , 2006, Acta Neuropathologica.

[43]  Bogdan Tanasa,et al.  A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function , 2006, Nature.

[44]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[45]  S. Feske,et al.  A severe defect in CRAC Ca2+ channel activation and altered K+ channel gating in T cells from immunodeficient patients , 2005, The Journal of experimental medicine.